# Premier Air Charter Holdings Inc.: financial statements, quarterly

PREM · OTC · CIK 1570937 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prem.md) · [Financials](/companies/prem/financials.md) · [Filings](/companies/prem/filings.md) · [Insiders](/companies/prem/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prem/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [5.9](/filings/0001683168-25-003676.md) | [5.4](/filings/0001683168-25-006197.md) | [4.0](/filings/0001683168-25-008436.md) | [5.5 d](/filings/0001683168-26-003005.md) | [5.9](/filings/0001683168-26-004025.md) | [7.4](/filings/0001683168-26-006482.md) | [7.1](/filings/0001683168-25-008436.md) | [11.5 d](/filings/0001683168-26-003005.md) | [7.2](/filings/0001683168-26-004025.md) | [5.8](/filings/0001683168-26-006482.md) |
| Cost of revenue | $m | not reported | not reported | [5.0](/filings/0001683168-25-003676.md) | [4.8](/filings/0001683168-25-006197.md) | [4.2](/filings/0001683168-25-008436.md) | [4.3 d](/filings/0001683168-26-003005.md) | [5.7](/filings/0001683168-26-004025.md) | [7.2](/filings/0001683168-26-006482.md) | [7.5](/filings/0001683168-25-008436.md) | [8.0 d](/filings/0001683168-26-003005.md) | [6.7](/filings/0001683168-26-004025.md) | [5.8](/filings/0001683168-26-006482.md) |
| Gross profit | $m | not reported | not reported | [0.9](/filings/0001683168-25-003676.md) | [0.5](/filings/0001683168-25-006197.md) | [(0.2)](/filings/0001683168-25-008436.md) | [1.1 d](/filings/0001683168-26-003005.md) | [0.1](/filings/0001683168-26-004025.md) | [0.2](/filings/0001683168-26-006482.md) | [(0.4)](/filings/0001683168-25-008436.md) | [3.5 d](/filings/0001683168-26-003005.md) | [0.5](/filings/0001683168-26-004025.md) | [(0.0)](/filings/0001683168-26-006482.md) |
| Selling, general and administrative | $m | not reported | not reported | [0.4](/filings/0001683168-25-003676.md) | [0.4](/filings/0001683168-25-006197.md) | [0.5](/filings/0001683168-25-008436.md) | [0.6 d](/filings/0001683168-26-003005.md) | [0.6](/filings/0001683168-26-004025.md) | [0.6](/filings/0001683168-26-006482.md) | [0.6](/filings/0001683168-25-008436.md) | [2.5 d](/filings/0001683168-26-003005.md) | [0.9](/filings/0001683168-26-004025.md) | [0.5](/filings/0001683168-26-006482.md) |
| Operating income | $m | [(0.1)](/filings/0001554795-24-000284.md) | [(0.0)](/filings/0001554795-25-000032.md) | [0.1](/filings/0001683168-25-003676.md) | [(0.3)](/filings/0001683168-25-006197.md) | [(0.9)](/filings/0001683168-25-008436.md) | [(0.0)](/filings/0001554795-25-000032.md) | [(0.9)](/filings/0001683168-26-004025.md) | [(0.8)](/filings/0001683168-26-006482.md) | [(1.5)](/filings/0001683168-25-008436.md) | [0.5 d](/filings/0001683168-26-003005.md) | [(0.7)](/filings/0001683168-26-004025.md) | [(0.9)](/filings/0001683168-26-006482.md) |
| Interest expense | $m | [0.0](/filings/0001554795-24-000284.md) | [0.0](/filings/0001554795-25-000032.md) | [0.0](/filings/0001683168-25-003676.md) | [0.0](/filings/0001554795-24-000215.md) | [0.0](/filings/0001554795-24-000284.md) | [0.0](/filings/0001554795-25-000032.md) | [0.3](/filings/0001683168-26-004025.md) | [0.3](/filings/0001683168-26-006482.md) | [0.3](/filings/0001683168-25-008436.md) | [0.4 d](/filings/0001683168-26-003005.md) | [0.4](/filings/0001683168-26-004025.md) | [0.4](/filings/0001683168-26-006482.md) |
| Net income | $m | [(0.0)](/filings/0001554795-25-000032.md) | [0.1](/filings/0001554795-25-000032.md) | [0.1](/filings/0001683168-25-008436.md) | [(0.5)](/filings/0001683168-25-008436.md) | [(1.2)](/filings/0001683168-25-008436.md) | [(0.0)](/filings/0001554795-25-000032.md) | [(1.2)](/filings/0001683168-26-006482.md) | [(1.0)](/filings/0001683168-26-006482.md) | [(1.8)](/filings/0001683168-25-008436.md) | [0.2 d](/filings/0001683168-26-003005.md) | [(1.2)](/filings/0001683168-26-006482.md) | [(1.3)](/filings/0001683168-26-006482.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.00](/filings/0001683168-25-003676.md) | [0.00](/filings/0001683168-25-006197.md) | [0.00](/filings/0001683168-25-008436.md) | not reported | [0.00](/filings/0001683168-26-004025.md) | [0.00](/filings/0001683168-26-006482.md) | [(0.01)](/filings/0001683168-25-008436.md) | not reported | [0.00](/filings/0001683168-26-004025.md) | [0.00](/filings/0001683168-26-006482.md) |
| Basic EPS | $ per share | not reported | not reported | [0.00](/filings/0001683168-25-003676.md) | [0.00](/filings/0001683168-25-006197.md) | [0.00](/filings/0001683168-25-008436.md) | not reported | [0.00](/filings/0001683168-26-004025.md) | [0.00](/filings/0001683168-26-006482.md) | [(0.01)](/filings/0001683168-25-008436.md) | not reported | [0.00](/filings/0001683168-26-004025.md) | [0.00](/filings/0001683168-26-006482.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001554795-23-000343.md) | [0.0](/filings/0001554795-24-000012.md) | [0.0](/filings/0001554795-25-000032.md) | [0.0](/filings/0001554795-24-000215.md) | [0.0](/filings/0001554795-24-000284.md) | [0.0](/filings/0001554795-25-000032.md) | [0.1](/filings/0001683168-25-003676.md) | [0.1](/filings/0001683168-25-006197.md) | [0.1](/filings/0001683168-25-008436.md) | [0.2](/filings/0001683168-26-003005.md) | not reported | not reported |
| Current assets | $m | [0.0](/filings/0001554795-23-000343.md) | [0.9](/filings/0001683168-25-002316.md) | [0.0](/filings/0001554795-25-000032.md) | [0.0](/filings/0001554795-24-000215.md) | [0.0](/filings/0001554795-24-000284.md) | [1.0](/filings/0001683168-26-003005.md) | [0.8](/filings/0001683168-25-003676.md) | [0.8](/filings/0001683168-25-006197.md) | [0.8](/filings/0001683168-25-008436.md) | [3.7](/filings/0001683168-26-006482.md) | [4.5](/filings/0001683168-26-004025.md) | [5.3](/filings/0001683168-26-006482.md) |
| Total assets | $m | [0.0](/filings/0001554795-23-000343.md) | [6.9](/filings/0001683168-25-002316.md) | [0.0](/filings/0001554795-25-000032.md) | [0.0](/filings/0001554795-24-000215.md) | [0.0](/filings/0001554795-24-000284.md) | [27.8](/filings/0001683168-26-003005.md) | [28.0](/filings/0001683168-25-003676.md) | [28.7](/filings/0001683168-25-006197.md) | [29.1](/filings/0001683168-25-008436.md) | [36.1](/filings/0001683168-26-006482.md) | [38.8](/filings/0001683168-26-004025.md) | [39.2](/filings/0001683168-26-006482.md) |
| Current liabilities | $m | [0.4](/filings/0001554795-23-000343.md) | [2.1](/filings/0001683168-25-002316.md) | [0.2](/filings/0001554795-25-000032.md) | [0.2](/filings/0001554795-24-000215.md) | [0.2](/filings/0001554795-24-000284.md) | [5.4](/filings/0001683168-26-003005.md) | [7.5](/filings/0001683168-25-003676.md) | [9.7](/filings/0001683168-25-006197.md) | [13.1](/filings/0001683168-25-008436.md) | [16.3](/filings/0001683168-26-006482.md) | [18.8](/filings/0001683168-26-004025.md) | [21.3](/filings/0001683168-26-006482.md) |
| Total liabilities | $m | [0.4](/filings/0001554795-23-000343.md) | [5.5](/filings/0001683168-25-002316.md) | [0.2](/filings/0001554795-25-000032.md) | [0.2](/filings/0001554795-24-000215.md) | [0.2](/filings/0001554795-24-000284.md) | [29.3](/filings/0001683168-26-003005.md) | [30.8](/filings/0001683168-25-003676.md) | [32.4](/filings/0001683168-25-006197.md) | [28.2](/filings/0001683168-25-008436.md) | [32.1](/filings/0001683168-26-006482.md) | [36.0](/filings/0001683168-26-004025.md) | [37.7](/filings/0001683168-26-006482.md) |
| Long-term debt | $m | not reported | [0.1](/filings/0001683168-25-002316.md) | not reported | not reported | not reported | [3.7](/filings/0001683168-26-003005.md) | [3.7](/filings/0001683168-25-003676.md) | [3.6](/filings/0001683168-25-006197.md) | [0.0](/filings/0001683168-25-008436.md) | [0.0](/filings/0001683168-26-006482.md) | [0.0](/filings/0001683168-26-004025.md) | [0.0](/filings/0001683168-26-006482.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001683168-25-002316.md) | not reported | not reported | not reported | [0.2](/filings/0001683168-26-003005.md) | [0.2](/filings/0001683168-25-003676.md) | [0.2](/filings/0001683168-25-006197.md) | [4.8](/filings/0001683168-25-008436.md) | [4.0](/filings/0001683168-26-006482.md) | [3.8](/filings/0001683168-26-004025.md) | [4.4](/filings/0001683168-26-006482.md) |
| Shareholders' equity | $m | [(0.4)](/filings/0001554795-25-000032.md) | [1.5](/filings/0001683168-26-003005.md) | [1.5](/filings/0001683168-25-008436.md) | [0.1](/filings/0001683168-25-008436.md) | [(1.0)](/filings/0001683168-25-008436.md) | [(1.6)](/filings/0001683168-26-006482.md) | [(2.8)](/filings/0001683168-26-006482.md) | [(3.8)](/filings/0001683168-26-006482.md) | [0.9](/filings/0001683168-25-008436.md) | [4.0](/filings/0001683168-26-006482.md) | [2.8](/filings/0001683168-26-006482.md) | [1.5](/filings/0001683168-26-006482.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(50.7) d](/filings/0001554795-24-000284.md) | [(7.9) d](/filings/0001554795-25-000032.md) | [358](/filings/0001683168-25-003676.md) | [(23.5)](/filings/0001554795-24-000215.md) | [1,424 d](/filings/0001683168-25-008436.md) | [929 d](/filings/0001683168-26-003005.md) | [995](/filings/0001683168-26-004025.md) | [1,212 d](/filings/0001683168-26-006482.md) | [(1,729) d](/filings/0001683168-25-008436.md) | [675 d](/filings/0001683168-26-003005.md) | [893](/filings/0001683168-26-004025.md) | [318 d](/filings/0001683168-26-006482.md) |
| Capital expenditure | $k | not reported | not reported | [0.0](/filings/0001683168-25-003676.md) | [285 d](/filings/0001683168-25-006197.md) | [846 d](/filings/0001683168-25-008436.md) | [362 d](/filings/0001683168-26-003005.md) | [691](/filings/0001683168-26-004025.md) | [723 d](/filings/0001683168-26-006482.md) | [630 d](/filings/0001683168-25-008436.md) | [508 d](/filings/0001683168-26-003005.md) | [367](/filings/0001683168-26-004025.md) | [510 d](/filings/0001683168-26-006482.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2017 (2016-09-30) | Q2 FY2018 (2017-09-30) | Q4 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.7](/filings/0001554795-18-000239.md) | [32.9](/filings/0001554795-18-000239.md) | [238](/filings/0001683168-25-003676.md) | [238](/filings/0001683168-25-006197.md) | [238](/filings/0001683168-25-008436.md) | [247](/filings/0001683168-26-004025.md) | [248](/filings/0001683168-26-006482.md) | [281](/filings/0001683168-25-008436.md) | [281](/filings/0001683168-26-004025.md) | [281](/filings/0001683168-26-006482.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 280,848,293 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001683168-26-006482.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.